KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Dividends Paid - Common (2016 - 2025)

Gilead Sciences (GILD) has disclosed Dividends Paid - Common for 12 consecutive years, with $994.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Dividends Paid - Common rose 2.16% year-over-year to $994.0 million, compared with a TTM value of $4.0 billion through Dec 2025, up 2.27%, and an annual FY2025 reading of $4.0 billion, up 2.17% over the prior year.
  • Dividends Paid - Common was $994.0 million for Q4 2025 at Gilead Sciences, down from $1.0 billion in the prior quarter.
  • Across five years, Dividends Paid - Common topped out at $1.0 billion in Q3 2025 and bottomed at $891.0 million in Q4 2021.
  • Average Dividends Paid - Common over 5 years is $952.4 million, with a median of $953.5 million recorded in 2023.
  • The sharpest move saw Dividends Paid - Common grew 5.77% in 2021, then grew 1.27% in 2023.
  • Year by year, Dividends Paid - Common stood at $891.0 million in 2021, then grew by 2.36% to $912.0 million in 2022, then increased by 4.17% to $950.0 million in 2023, then grew by 2.42% to $973.0 million in 2024, then increased by 2.16% to $994.0 million in 2025.
  • Business Quant data shows Dividends Paid - Common for GILD at $994.0 million in Q4 2025, $1.0 billion in Q3 2025, and $997.0 million in Q2 2025.